Quantcast
Channel: cafepharma - Concerta
Browsing all 14 articles
Browse latest View live

News

J&J, Watson weigh options after court rules patent on J&J ADHD drug Concerta is invalid Yahoo/AP

View Article


News

Drugmakers Nix Long-Term Study On ADHD Meds Pharmalot

View Article


News

J&J unit denied appeal of ADHD patent decision Marketwatch

View Article

News

New Data Analyses on CONCERTA Pediatric Treatment Include Insight on Handwriting Performance and Attention in ADHD Pipeline Review

View Article

News

J&J, Watson sign deal for generic Concerta Yahoo/AP

View Article


News

Johnson & Johnson Units Sue Teva, Impax Over Generic Concerta Bloomberg

View Article

J&J Files New Concerta Lawsuit Against Impax Labs

J&J Files New Concerta Lawsuit Against Impax Labs Drug Discovery & Development

View Article

Hyperactivity Drugs Shown Not to Raise Heart Risks in Children

Hyperactivity Drugs Shown Not to Raise Heart Risks in Children Bloomberg

View Article


Attention Deficit Drugs Don’t Raise Adults’ Heart Risk in Study Q

Attention Deficit Drugs Don’t Raise Adults’ Heart Risk in Study Bloomberg

View Article


Impax says its generic version of Concerta will go on sale in July 2013 in...

Impax says its generic version of Concerta will go on sale in July 2013 in settlement with J&J Yahoo/AP

View Article

Impax and J&J settle Concerta patent lawsuits

Impax and J&J settle Concerta patent lawsuits Equities.com

View Article

FDA Approves Covidien Drug

FDA Approves Covidien Drug Yahoo/Zacks

View Article

A Closer Look at the Controversial Market Growth of ADHD Treatments

A Closer Look at the Controversial Market Growth of ADHD Treatments Motley Fool

View Article


FDA Puts Out Warning on J&J, Novartis ADHD Drugs

FDA Puts Out Warning on J&J, Novartis ADHD Drugs Wall St Cheat Sheet

View Article
Browsing all 14 articles
Browse latest View live